<DOC>
	<DOC>NCT02211053</DOC>
	<brief_summary>The purpose of this study is to evaluate if the administration of an infusion of levothyroxine can improve heart function in organ donors</brief_summary>
	<brief_title>Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controled Trial</brief_title>
	<detailed_description />
	<mesh_term>Brain Death</mesh_term>
	<criteria>Prior signed written informed from family member 16 years of age or older Brain death diagnosis Left ventricular ejection fraction &lt; 50% determined by transthoracic echocardiography or hemodynamic instability defined as a mean dose of noradrenaline 0.1 mcg/kg/min + vasopressin Heart failure history Chronic exogenous oral T4 or T3 before death Having received T4 infusion before recruitment Echographic images not interpretable Age 75 and older Prior coronary heart disease defined as prior coronary artery bypass graft or percutaneous coronary intervention (with or without stents)</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Organ donation</keyword>
	<keyword>Brain dead</keyword>
	<keyword>Levothyroxine</keyword>
</DOC>